Research progress in population pharmacokinetics of rituximab / 中国临床药理学与治疗学
Chinese Journal of Clinical Pharmacology and Therapeutics
; (12): 468-474, 2023.
Article
ي Zh
| WPRIM
| ID: wpr-1014654
المكتبة المسؤولة:
WPRO
ABSTRACT
Rituximab, a chimeric human-mouse monoclonal antibody, has been used as a first-line treatment for CD20
النص الكامل:
1
الفهرس:
WPRIM
اللغة:
Zh
مجلة:
Chinese Journal of Clinical Pharmacology and Therapeutics
السنة:
2023
نوع:
Article